Lybalvi 5-10 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FRNY6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,194
Award facts
- Contract value 100% obligated
- $15,193.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,193.94 to AmerisourceBergen Drug Corp for the supply of Lybalvi 5-10 mg tablets (30-count units) on June 30, 2025, with an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier to federal medical procurement needs, particularly for military and veteran healthcare systems. The company's SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. This delivery order for Lybalvi, an antipsychotic medication, exemplifies the company's role in fulfilling federal medical supply requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FRNY6?
SPE2DB25FRNY6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 30, 2025.
How much is contract SPE2DB25FRNY6 worth?
The government has obligated $15,194 on SPE2DB25FRNY6.
Is contract SPE2DB25FRNY6 an order under another contract?
Yes. SPE2DB25FRNY6 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRNY6 competed?
The extent of competition for SPE2DB25FRNY6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award